GO:1905213 negative regulation of mitotic chromosome condensation: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905213 describes any process that stops, prevents or reduces the frequency, rate or extent of mitotic chromosome condensation.
• Mitotic chromosome condensation is driven by condensin complexes and modulated by phosphorylation, SUMOylation and chromatin-binding proteins.
• Negative regulation of condensation is essential for faithful sister chromatid resolution and mitotic exit.
• Key proteins implicated include topoisomerase II (TOP2A), HMGN proteins, p73, and SUMO-2/3 conjugates.
• Dysregulation of condensation control contributes to chromosomal instability, a hallmark of many cancers.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of this regulatory process.
Description
Mitotic chromosome condensation is a fundamental cell-cycle event that packages interphase chromatin into compact, discrete chromosomes, enabling faithful segregation of genetic material. The Gene Ontology term GO:1905213, negative regulation of mitotic chromosome condensation, captures the regulatory processes that restrain, delay or reverse this compaction. Understanding this negative regulation is critical because both excessive and insufficient condensation can lead to aneuploidy, chromosomal instability and cell death. Research over the past two decades has revealed that condensation is not a simple on/off switch but a finely tuned equilibrium controlled by kinases, SUMOylation machinery, topoisomerases and chromatin architectural proteins. For example, SUMO-2/3 modification of topoisomerase II regulates its mitotic functions, while mitotic phosphorylation of HMGN proteins evicts them from chromatin, thereby modulating condensation states. The p73 tumor suppressor has also been linked to mitotic exit, indirectly influencing condensation dynamics. For researchers, GO:1905213 provides a structured framework to annotate genes and pathways that oppose condensation. This article synthesizes authoritative QuickGO data and verified PubMed literature to outline the mechanisms, key genes, disease relevance and experimental models for studying negative regulation of mitotic chromosome condensation.
negative regulation of mitotic chromosome condensation At A Glance
| GO ID | GO:1905213 |
|---|---|
| GO term | negative regulation of mitotic chromosome condensation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Restrains or reverses mitotic chromosome compaction to ensure faithful chromosome segregation and mitotic exit |
| Related processes | Sister chromatid resolution, mitotic exit, chromatin remodeling |
| Key regulators | SUMO-2/3, topoisomerase II, HMGN proteins, p73 |
| Disease relevance | Chromosomal instability in cancer, radiosensitivity |
What Is GO:1905213?
GO:1905213 is a biological process term defined as any process that stops, prevents or reduces the frequency, rate or extent of mitotic chromosome condensation. In other words, it encompasses molecular events that actively counteract the compaction of chromatin into mitotic chromosomes, ensuring proper temporal and spatial control of chromosome architecture during cell division.
Why Is negative regulation of mitotic chromosome condensation Important in Cell Biology?
Negative regulation of mitotic chromosome condensation is essential for maintaining genomic stability. Without proper restraint of condensation, cells risk incomplete sister chromatid resolution, anaphase bridges and aneuploidy, all of which are hallmarks of cancer and developmental disorders. Moreover, the interplay between condensation and transcription during mitosis-to-G1 transition influences cell fate decisions in stem cells. Understanding this process also has clinical implications for radiosensitivity, as individual variations in condensation control can affect DNA damage responses.
• Prevents premature or excessive chromosome compaction that could block sister chromatid resolution.
• Facilitates mitotic exit by allowing chromatin decondensation and nuclear envelope reformation.
• Regulates topoisomerase II activity via SUMOylation to avoid DNA entanglements.
• Modulates chromatin binding of HMGN proteins through mitotic phosphorylation.
• Influences transcriptional reactivation during mitosis-to-G1 transition in neural stem cells.
• Contributes to chromosomal instability in androgen receptor-low triple-negative breast cancer.
• Affects individual radiosensitivity in normal human fibroblasts.
• Provides targets for cancer therapeutics aimed at exploiting condensation vulnerabilities.
• Helps explain hyperthermic-induced rDNA hypercondensation in yeast models.
• Offers a framework for annotating genes that oppose condensation in genome-wide studies.
What Happens During negative regulation of mitotic chromosome condensation?
Initiation of negative regulation
In simple terms: The cell starts to put the brakes on chromosome tightening.
Negative regulation of mitotic chromosome condensation is initiated by signaling events that recruit inhibitory factors to chromatin. SUMO-2/3 conjugation to topoisomerase II during mitosis is one such event that modulates its activity and indirectly restrains condensation. Additionally, mitotic phosphorylation of HMGN proteins prevents their binding to chromatin, reducing their compaction-promoting effects.
Chromatin remodeling and histone modifications
In simple terms: Proteins that normally pack DNA are removed or modified to loosen the structure.
Chromatin remodeling complexes and histone modifications contribute to negative regulation. For instance, phosphorylation of HMGN proteins by mitotic kinases disrupts their interaction with nucleosomes, leading to a more open chromatin state. This process is coordinated with sister chromatid resolution, where cohesin complexes are removed to allow individual chromatids to separate.
Coordination with mitotic exit
In simple terms: As cells finish division, they must unpack chromosomes again.
Negative regulation is tightly coupled to mitotic exit. The p73 tumor suppressor has been implicated in mitotic exit, and its loss leads to defects in chromosome decondensation and cytokinesis. This suggests that p73 may directly or indirectly promote the reversal of condensation as cells transition to G1.
Transcriptional reactivation and cell fate
In simple terms: Unpacking chromosomes allows genes to be read again after division.
After mitosis, chromatin must decondense to allow transcription. In neural stem cells, hierarchical reactivation of transcription during mitosis-to-G1 transition is driven by factors such as Brn2 and Ascl1, which require a permissive chromatin state. Negative regulation of condensation thus facilitates the resumption of gene expression programs.
Key Genes Involved in GO:1905213 negative regulation of mitotic chromosome condensation
The following genes and proteins have been experimentally linked to negative regulation of mitotic chromosome condensation or related processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TOP2A | Topoisomerase II; regulated by SUMO-2/3 during mitosis | Target for studying SUMOylation in condensation control |
| HMGN1 | Chromatin architectural protein; phosphorylated in mitosis to prevent chromatin binding | Model for phosphorylation-dependent condensation regulation |
| HMGN2 | Similar to HMGN1; mitotic phosphorylation evicts from chromatin | Studying chromatin decompaction mechanisms |
| TP73 | p73 tumor suppressor; involved in mitotic exit | Linking mitotic exit to condensation reversal |
| SUMO2 | SUMO-2/3 conjugation regulates topoisomerase II | Investigating SUMOylation in mitosis |
| SUMO3 | SUMO-2/3 conjugation regulates topoisomerase II | Investigating SUMOylation in mitosis |
| FOXM1 | Transcription factor upregulating mitotic progression proteins | Studying chromosomal instability in breast cancer |
| BRN2 | Transcription factor reactivating genes post-mitosis | Neural stem cell fate and chromatin state |
| ASCL1 | Transcription factor reactivating genes post-mitosis | Neural stem cell fate and chromatin state |
| SMC2 | Condensin subunit; opposes negative regulation | Understanding balance of condensation |
| SMC4 | Condensin subunit; opposes negative regulation | Understanding balance of condensation |
| RAD21 | Cohesin subunit; involved in sister chromatid resolution | Studying cohesin removal |
| CDK1 | Mitotic kinase; phosphorylates HMGN proteins | Kinase regulation of condensation |
| AURKB | Aurora kinase B; implicated in mitotic phosphorylation | Potential upstream regulator |
| PLK1 | Polo-like kinase 1; mitotic regulator | Coordination with condensation machinery |
| WAPL | Cohesin releasing factor | Sister chromatid resolution |
| PDS5 | Cohesin-associated protein | Resolution and condensation balance |
How Is negative regulation of mitotic chromosome condensation Regulated?
Negative regulation of mitotic chromosome condensation is itself regulated by upstream signaling pathways. SUMOylation machinery, particularly SUMO-2/3, modifies topoisomerase II to modulate its activity during mitosis. Mitotic kinases such as CDK1 and Aurora B phosphorylate HMGN proteins, preventing their chromatin binding and thereby reducing compaction. Additionally, the p73 pathway influences mitotic exit, which is coupled to decondensation. In neural stem cells, transcription factors Brn2 and Ascl1 coordinate the reactivation of gene expression after mitosis, requiring a decondensed chromatin state.
negative regulation of mitotic chromosome condensation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FOXM1 | Triple-negative breast cancer, chromosomal instability | Knockout in breast cancer cell lines |
| TP73 | Mitotic exit defects, potential tumor suppression | Point mutation or knockout in cancer cells |
| TOP2A | Chemotherapy resistance, genomic instability | SUMOylation-site knock-in |
| HMGN1/2 | Chromatin regulation in cancer and development | Phospho-mutant knock-in |
| SUMO2/3 | Mitotic regulation, cancer | Knockout or overexpression |
Cancer and chromosomal instability
Dysregulation of mitotic chromosome condensation control is linked to chromosomal instability (CIN), a hallmark of many cancers. In androgen receptor-low triple-negative breast cancer, the FOXM1 signaling network transcriptionally upregulates proteins involved in mitotic progression, inducing high proliferation and CIN. This suggests that loss of negative regulation can drive tumorigenesis.
Radiosensitivity
Individual variations in radiosensitivity have been associated with molecular mechanisms that include chromatin condensation states. Studies in normal diploid human fibroblasts indicate that differences in condensation control can affect DNA damage responses and cell survival after irradiation.
Neural stem cell fate and neurodevelopment
Proper negative regulation of condensation is required for transcriptional reactivation during mitosis-to-G1 transition in neural stem cells. Factors such as Brn2 and Ascl1 orchestrate this process, and their dysfunction could impact neurodevelopment.
From negative regulation of mitotic chromosome condensation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate mitotic chromosome condensation? | CRISPR knockout followed by live-cell imaging of chromosome compaction |
| What is the role of a specific phosphorylation site in HMGN proteins? | Point mutation (phospho-null or phospho-mimetic) knock-in |
| How does SUMOylation of TOP2A affect condensation? | Knock-in of SUMOylation-deficient TOP2A |
| Can overexpression of a candidate gene reduce condensation? | Doxycycline-inducible overexpression cell line |
| What is the interactome of a negative regulator during mitosis? | Tagged knock-in (e.g., GFP) followed by immunoprecipitation |
| Does loss of p73 affect mitotic exit and decondensation? | p73 knockout cells synchronized in mitosis |
How to Study the negative regulation of mitotic chromosome condensation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging (H2B-GFP) | Chromosome condensation/decondensation dynamics | Real-time assessment of GO:1905213 |
| Phosphoproteomics | Mitotic phosphorylation events | Identify regulators like HMGN |
| SUMOylation assay | SUMO-2/3 conjugation to targets | Study TOP2A regulation |
| Chromosome spreads + FISH | Chromosome morphology and sister resolution | Detect resolution defects |
| RNA-seq | Transcriptional reactivation post-mitosis | Neural stem cell fate |
| Immunoprecipitation + MS | Protein-protein interactions | Identify complexes |
| CRISPR screening | Genome-wide identification of regulators | Discover novel negative regulators |
| Flow cytometry | Cell cycle profile and mitotic index | Validate perturbations |
Live-cell imaging of chromosome condensation
Live-cell imaging using histone H2B-GFP or similar fluorescent reporters allows real-time monitoring of chromosome compaction and decondensation dynamics in individual cells. This method is essential for quantifying the effects of genetic perturbations on GO:1905213.
Phosphoproteomics and SUMOylation assays
Mass spectrometry-based phosphoproteomics and SUMOylation assays can identify post-translational modifications on proteins such as HMGN and topoisomerase II that regulate condensation.
Chromosome spreads and FISH
Mitotic chromosome spreads combined with fluorescence in situ hybridization (FISH) enable visualization of chromosome morphology and sister chromatid resolution defects upon perturbation of negative regulators.
Transcriptional profiling during mitosis-to-G1 transition
RNA-seq of synchronized cells released from mitosis can reveal how decondensation affects transcriptional reactivation, as shown for Brn2 and Ascl1 in neural stem cells.
How CRISPR Can Be Used to Study GO:1905213 negative regulation of mitotic chromosome condensation
Knockout
CRISPR knockout of candidate genes (e.g., TP73, HMGN1) can be used to test whether loss of function leads to hypercondensation or defects in mitotic exit. This is a direct way to assess negative regulation.
Point Mutation
Point mutations can be introduced to abrogate specific post-translational modification sites, such as phosphorylation sites in HMGN proteins or SUMOylation sites in TOP2A, to dissect their role in condensation control.
Knock-in
Knock-in of tagged versions (e.g., GFP, HaloTag) of negative regulators allows live-cell imaging and proteomic analysis of their dynamics and interactions during mitosis.
Overexpression
Overexpression of candidate negative regulators can be achieved via lentiviral or inducible systems to test whether increased dosage reduces condensation and affects cell cycle progression.
How EDITGENE Supports negative regulation of mitotic chromosome condensation Research
Researchers studying negative regulation of mitotic chromosome condensation-related genes often need to determine whether a candidate gene is causally involved in restraining chromosome compaction, and which domains or modifications are required. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mitotic chromosome condensation research.
Frequently Asked Questions About negative regulation of mitotic chromosome condensation
What is GO:1905213?
GO:1905213 is the Gene Ontology term for negative regulation of mitotic chromosome condensation, defined as any process that stops, prevents or reduces the frequency, rate or extent of mitotic chromosome condensation.
What genes are involved in negative regulation of mitotic chromosome condensation?
Key genes include TOP2A, HMGN1, HMGN2, TP73, SUMO2, SUMO3, and FOXM1, among others.
How is mitotic chromosome condensation negatively regulated?
It is regulated by post-translational modifications such as SUMOylation of topoisomerase II and phosphorylation of HMGN proteins, which reduce chromatin compaction.
Why is negative regulation of chromosome condensation important?
It ensures proper sister chromatid resolution, mitotic exit, and genomic stability; dysregulation can lead to chromosomal instability and cancer.
What diseases are associated with defects in this process?
Chromosomal instability in cancers such as triple-negative breast cancer, and altered radiosensitivity in normal fibroblasts.
What methods are used to study negative regulation of mitotic chromosome condensation?
Live-cell imaging, phosphoproteomics, chromosome spreads, RNA-seq, and CRISPR screens are commonly used.
Can CRISPR be used to study this process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in this pathway.
What is the role of p73 in mitotic chromosome condensation?
p73 is involved in mitotic exit, and its loss leads to defects in chromosome decondensation and cytokinesis.
How does SUMOylation affect topoisomerase II in mitosis?
SUMO-2/3 conjugation regulates topoisomerase II activity during mitosis, influencing chromosome condensation and segregation.
What is the connection between FOXM1 and chromosomal instability?
FOXM1 transcriptionally upregulates mitotic progression proteins, and its activity is linked to high proliferation and chromosomal instability in androgen receptor-low triple-negative breast cancer.
Conclusion
GO:1905213, negative regulation of mitotic chromosome condensation, represents a critical layer of control in cell division. By restraining chromosome compaction, cells ensure proper sister chromatid resolution, mitotic exit, and transcriptional reactivation. Dysregulation of this process contributes to chromosomal instability and cancer, making it a compelling area for both basic and translational research. With the availability of CRISPR-based models and advanced imaging and proteomic methods, researchers are now well-equipped to dissect the molecular players and regulatory mechanisms underlying this process. EDITGENE offers comprehensive services to accelerate such discoveries.
References
- 1. Rida P et al.. 2026. FOXM1 Signaling Network Transcriptionally Upregulates Expression of Proteins Involved in Mitotic Progression to Induce High Proliferation and Chromosomal Instability in Androgen Receptor-Low Triple-Negative Breast Cancer.. Int J Mol Sci 27(4) PMID: 41751958
- 2. Shen D et al.. 2020. Promotion of Hyperthermic-Induced rDNA Hypercondensation in Saccharomyces cerevisiae.. Genetics 214(3):589-604 PMID: 31980450
- 3. Azuma Y et al.. 2003. SUMO-2/3 regulates topoisomerase II in mitosis.. J Cell Biol 163(3):477-87 PMID: 14597774
- 4. Merlo P et al.. 2005. A role of p73 in mitotic exit.. J Biol Chem 280(34):30354-60 PMID: 15985436
- 5. Shintomi K et al.. 2010. Sister chromatid resolution: a cohesin releasing network and beyond.. Chromosoma 119(5):459-67 PMID: 20352243
- 6. Soares MAF et al.. 2021. Hierarchical reactivation of transcription during mitosis-to-G1 transition by Brn2 and Ascl1 in neural stem cells.. Genes Dev 35(13-14):1020-1034 PMID: 34168041
- 7. Prymakowska-Bosak M et al.. 2001. Mitotic phosphorylation prevents the binding of HMGN proteins to chromatin.. Mol Cell Biol 21(15):5169-78 PMID: 11438671
- 8. Dikomey E et al.. 2003. Molecular mechanisms of individual radiosensitivity studied in normal diploid human fibroblasts.. Toxicology 193(1-2):125-35 PMID: 14599772
